MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation EV - Enterprise Value 2011-2026 | EW
Annual EV - Enterprise Value Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.3 B | 42.4 B | 54.5 B | 49.5 B | 71.8 B | 53.2 B | 49.9 B | 36.8 B | 28.7 B | 21.5 B | 17.7 B | 14 B | 8.06 B | 10.8 B | 9.44 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.8 B | 8.06 B | 34.5 B |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sensus Healthcare
SRTS
|
55.2 M | $ 3.88 | -3.24 % | $ 63.3 M |  USA |
 |
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Tactile Systems Technology
TCMD
|
611 M | $ 26.41 | -1.39 % | $ 604 M | USA |
 |
TELA Bio
TELA
|
56.7 M | $ 0.71 | -4.84 % | $ 33.3 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
Tandem Diabetes Care
TNDM
|
1.9 B | $ 22.21 | -4.76 % | $ 1.51 B | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 36.63 | -0.03 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3.17 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
170 M | $ 24.45 | - | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
Viemed Healthcare
VMD
|
395 M | $ 9.16 | -0.65 % | $ 356 M | USA |
 |
Outset Medical
OM
|
103 M | $ 3.43 | -2.7 % | $ 52.2 K | USA |
 |
Vivos Therapeutics
VVOS
|
15.4 M | $ 1.19 | 0.02 % | $ 5.97 M | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
87.4 M | $ 0.62 | 3.32 % | $ 33.7 M | USA |
 |
Aethlon Medical
AEMD
|
-237 K | $ 2.23 | -1.76 % | $ 3.48 M | USA |
 |
PAVmed
PAVM
|
53.5 M | $ 8.91 | -0.28 % | $ 64.4 M | USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
120 M | $ 1.7 | -1.73 % | $ 109 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
3.89 B | $ 11.32 | -0.79 % | $ 1.53 B | USA |
 |
Sintx Technologies
SINT
|
9.34 M | $ 2.45 | 1.24 % | $ 6.8 M | USA |
 |
Penumbra
PEN
|
13.4 B | $ 335.61 | -0.24 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
699 M | $ 3.87 | -1.78 % | $ 572 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-6.79 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
47 M | $ 0.66 | -2.85 % | $ 27.6 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 49.09 | -2.7 % | $ 1.44 B | USA |
 |
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.21 | -2.82 % | $ 49.2 M | USA |
 |
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
2.04 B | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M | USA |